Wed Sep 10 03:22:09 UTC 2025: Okay, here’s a summary and a news article based on the text you provided:

**Summary:**

The World Health Organization (WHO) is now recommending the use of popular weight-loss drugs for the treatment of diabetes and obesity worldwide. Critically, the WHO is urging the production and availability of affordable, generic versions of these drugs, particularly for people in developing nations.

**News Article:**

**WHO Endorses Weight-Loss Drugs for Diabetes and Obesity, Calls for Affordable Generics in Developing World**

GENEVA – In a landmark move that could reshape the fight against diabetes and obesity, the World Health Organization (WHO) has issued its first-ever recommendation for the use of a range of popular weight-loss drugs in treating these conditions globally. The announcement, made Friday, signals a significant shift in the WHO’s approach to addressing the growing burden of metabolic diseases worldwide.

While acknowledging the effectiveness of these medications, the WHO is emphasizing the urgent need for access in low- and middle-income countries. The organization is specifically advocating for the production and distribution of affordable, generic versions of the drugs, which are currently often prohibitively expensive for people in developing nations.

“Obesity and diabetes are rapidly increasing in many parts of the world, especially in lower-income countries,” said a WHO spokesperson. “These medications can be a powerful tool, but only if they are accessible to those who need them most. We are urging pharmaceutical companies and governments to work together to ensure affordable access to these life-changing treatments.”

The specific drugs included in the WHO’s recommendation were not immediately disclosed, but experts believe it encompasses medications like GLP-1 receptor agonists, which have shown significant promise in both weight loss and blood sugar control.

The WHO’s announcement is expected to spark debate about the role of medication in addressing complex health issues like obesity and diabetes, as well as the ethical considerations surrounding access to potentially life-saving drugs in a globalized world.

Read More